These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29674173)

  • 21. Artificial intelligence and digital biomarker in precision pathology guiding immune therapy selection and precision oncology.
    Huss R; Raffler J; Märkl B
    Cancer Rep (Hoboken); 2023 Jul; 6(7):e1796. PubMed ID: 36813293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics.
    Barbieri CE; Chinnaiyan AM; Lerner SP; Swanton C; Rubin MA
    Eur Urol; 2017 Feb; 71(2):237-246. PubMed ID: 27567210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Towards personalized computational oncology: from spatial models of tumour spheroids, to organoids, to tissues.
    Karolak A; Markov DA; McCawley LJ; Rejniak KA
    J R Soc Interface; 2018 Jan; 15(138):. PubMed ID: 29367239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational modeling in melanoma for novel drug discovery.
    Pennisi M; Russo G; Di Salvatore V; Candido S; Libra M; Pappalardo F
    Expert Opin Drug Discov; 2016 Jun; 11(6):609-21. PubMed ID: 27046143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated PK-PD and agent-based modeling in oncology.
    Wang Z; Butner JD; Cristini V; Deisboeck TS
    J Pharmacokinet Pharmacodyn; 2015 Apr; 42(2):179-89. PubMed ID: 25588379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omics sciences and precision medicine in glioblastoma.
    Micheletti C; Bonetti G; Madeo G; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Manganotti P; Caruso P; Bernini A; Fulcheri E; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):77-84. PubMed ID: 37994751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mathematical Modeling of the Effects of Tumor Heterogeneity on the Efficiency of Radiation Treatment Schedule.
    Forouzannia F; Enderling H; Kohandel M
    Bull Math Biol; 2018 Feb; 80(2):283-293. PubMed ID: 29218592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methodologies in the modeling of combined chemo-radiation treatments.
    Grassberger C; Paganetti H
    Phys Med Biol; 2016 Nov; 61(21):R344-R367. PubMed ID: 27758980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmenting Surgery via Multi-scale Modeling and Translational Systems Biology in the Era of Precision Medicine: A Multidisciplinary Perspective.
    Kassab GS; An G; Sander EA; Miga MI; Guccione JM; Ji S; Vodovotz Y
    Ann Biomed Eng; 2016 Sep; 44(9):2611-25. PubMed ID: 27015816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How Advances in Imaging Will Affect Precision Radiation Oncology.
    Jaffray DA; Das S; Jacobs PM; Jeraj R; Lambin P
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):292-298. PubMed ID: 29726358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrating mechanism-based modeling with biomedical imaging to build practical digital twins for clinical oncology.
    Wu C; Lorenzo G; Hormuth DA; Lima EABF; Slavkova KP; DiCarlo JC; Virostko J; Phillips CM; Patt D; Chung C; Yankeelov TE
    Biophys Rev (Melville); 2022 Jun; 3(2):021304. PubMed ID: 35602761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic/pharmacodynamic modeling of combination-chemotherapy for lung cancer.
    Curtis LT; van Berkel VH; Frieboes HB
    J Theor Biol; 2018 Jul; 448():38-52. PubMed ID: 29614265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion.
    Pinton P
    Ann Med; 2023; 55(2):2300670. PubMed ID: 38163336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translational modeling and simulation approaches for molecularly targeted small molecule anticancer agents from bench to bedside.
    Yamazaki S; Spilker ME; Vicini P
    Expert Opin Drug Metab Toxicol; 2016; 12(3):253-65. PubMed ID: 26799750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.
    Schmidt KT; Chau CH; Price DK; Figg WD
    J Clin Pharmacol; 2016 Dec; 56(12):1484-1499. PubMed ID: 27197880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer in the era of precision medicine.
    Sarhangi N; Hajjari S; Heydari SF; Ganjizadeh M; Rouhollah F; Hasanzad M
    Mol Biol Rep; 2022 Oct; 49(10):10023-10037. PubMed ID: 35733061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depression and medical illness in late life: report of a symposium.
    Lyness JM; Bruce ML; Koenig HG; Parmelee PA; Schulz R; Lawton MP; Reynolds CF
    J Am Geriatr Soc; 1996 Feb; 44(2):198-203. PubMed ID: 8576513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.